Last July, the National Institutes of Health and the Food and Drug Administration announced that they would begin tripling the amount of annual funding for a new clinical proteomics program. Now it seems the money has begun to bear fruit. Last week, Emanuel Petricoin and Lance Liotta, co-directors of the program, and their colleagues published a paper in The Lancet describing a diagnostic test for ovarian cancer based on serum protein profiles.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.